GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (STU:A71) » Definitions » Cyclically Adjusted Book per Share

Ascendis Pharma A/S (STU:A71) Cyclically Adjusted Book per Share : €8.64 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ascendis Pharma A/S Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Ascendis Pharma A/S's adjusted book value per share for the three months ended in Mar. 2024 was €-4.170. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €8.64 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Ascendis Pharma A/S's average Cyclically Adjusted Book Growth Rate was -6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-10), Ascendis Pharma A/S's current stock price is €125.00. Ascendis Pharma A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €8.64. Ascendis Pharma A/S's Cyclically Adjusted PB Ratio of today is 14.47.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Ascendis Pharma A/S was 15.97. The lowest was 6.71. And the median was 9.49.


Ascendis Pharma A/S Cyclically Adjusted Book per Share Historical Data

The historical data trend for Ascendis Pharma A/S's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Cyclically Adjusted Book per Share Chart

Ascendis Pharma A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 8.95

Ascendis Pharma A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.48 9.17 9.53 8.95 8.64

Competitive Comparison of Ascendis Pharma A/S's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Ascendis Pharma A/S's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma A/S's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's Cyclically Adjusted PB Ratio falls into.



Ascendis Pharma A/S Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ascendis Pharma A/S's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-4.17/118.4000*118.4000
=-4.170

Current CPI (Mar. 2024) = 118.4000.

Ascendis Pharma A/S Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 99.700 0.000
201409 0.148 99.700 0.176
201412 2.705 99.400 3.222
201503 6.259 100.200 7.396
201506 5.609 100.300 6.621
201509 5.242 100.200 6.194
201512 4.789 99.800 5.682
201603 4.056 100.200 4.793
201606 3.618 100.600 4.258
201609 2.951 100.200 3.487
201612 5.447 100.300 6.430
201703 4.764 101.200 5.574
201706 3.891 101.200 4.552
201709 5.559 101.800 6.465
201712 5.062 101.300 5.916
201803 8.367 101.700 9.741
201806 7.940 102.300 9.190
201809 7.237 102.400 8.368
201812 6.646 102.100 7.707
201903 15.272 102.900 17.572
201906 14.199 102.900 16.338
201909 13.844 102.900 15.929
201912 12.444 102.900 14.318
202003 11.437 103.300 13.109
202006 9.869 103.200 11.323
202009 17.815 103.500 20.380
202012 15.604 103.400 17.868
202103 14.914 104.300 16.930
202106 12.755 105.000 14.383
202109 17.468 105.800 19.548
202112 15.519 106.600 17.237
202203 12.057 109.900 12.990
202206 10.891 113.600 11.351
202209 7.918 116.400 8.054
202212 4.608 115.900 4.707
202303 2.974 117.300 3.002
202306 1.153 116.400 1.173
202309 -1.299 117.400 -1.310
202312 -2.573 116.700 -2.610
202403 -4.170 118.400 -4.170

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Ascendis Pharma A/S  (STU:A71) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ascendis Pharma A/S's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=125.00/8.64
=14.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Ascendis Pharma A/S was 15.97. The lowest was 6.71. And the median was 9.49.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Ascendis Pharma A/S Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Pharma A/S (STU:A71) Business Description

Industry
Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Ascendis Pharma A/S (STU:A71) Headlines

No Headlines